DE SIMONE FORMULATION Trademark

Trademark Overview


On Wednesday, February 12, 2020, a trademark application was filed for DE SIMONE FORMULATION with the United States Patent and Trademark Office. The USPTO has given the DE SIMONE FORMULATION trademark a serial number of 88794812. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by ExeGi Pharma, LLC. The DE SIMONE FORMULATION trademark is filed in the Pharmaceutical Products category with the following description:

Food supplements; Food supplements for treating digestive disorders; Health food supplements; Nutritional supplements, namely, probiotic compositions; Dietary and nutritional supplements; Live biotherapeutics for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases; Medical Food, namely, dietetic foods in the nature of powder specially adapted for medical use; Probiotic supplements; lactic acid bacteria compositions for use as a human drug for treating diseases of the gastro-intestinal tract, diseases of the oral cavity and vaginal diseases; lactic acid bacteria compositions for use as a veterinary drug for treating diseases of the gastro-intestinal tract, diseases of the oral cavity and vaginal diseases; lactic acid bacteria compositions for use as a dietary or food supplement; veterinary supplements; veterinary probiotic supplements
de simone formulation

General Information


Serial Number88794812
Word MarkDE SIMONE FORMULATION
Filing DateWednesday, February 12, 2020
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6721007
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 22, 2022

Trademark Statements


Goods and ServicesFood supplements; Food supplements for treating digestive disorders; Health food supplements; Nutritional supplements, namely, probiotic compositions; Dietary and nutritional supplements; Live biotherapeutics for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases; Medical Food, namely, dietetic foods in the nature of powder specially adapted for medical use; Probiotic supplements; lactic acid bacteria compositions for use as a human drug for treating diseases of the gastro-intestinal tract, diseases of the oral cavity and vaginal diseases; lactic acid bacteria compositions for use as a veterinary drug for treating diseases of the gastro-intestinal tract, diseases of the oral cavity and vaginal diseases; lactic acid bacteria compositions for use as a dietary or food supplement; veterinary supplements; veterinary probiotic supplements
Section 2(f) Limitation Statementas to DE SIMONE
Disclaimer with Predetermined Text"FORMULATION"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 18, 2020
Primary Code005
First Use Anywhere DateMonday, November 30, 2015
First Use In Commerce DateMonday, November 30, 2015

Trademark Owner History


Party NameExeGi Pharma, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20850

Party NameExeGi Pharma, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20850

Party NameExeGi Pharma, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, February 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 22, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, June 24, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, June 24, 2021FINAL REFUSAL E-MAILED
Thursday, June 24, 2021FINAL REFUSAL WRITTEN
Wednesday, June 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 30, 2020NON-FINAL ACTION E-MAILED
Monday, November 30, 2020NON-FINAL ACTION WRITTEN
Friday, November 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 6, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 6, 2020NON-FINAL ACTION WRITTEN
Thursday, April 30, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 15, 2020NEW APPLICATION ENTERED IN TRAM